BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18597400)

  • 1. Prognostic factors for survival in scleroderma associated pulmonary arterial hypertension.
    Johnson SR; Swiston JR; Granton JT
    J Rheumatol; 2008 Aug; 35(8):1584-90. PubMed ID: 18597400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis.
    Lefèvre G; Dauchet L; Hachulla E; Montani D; Sobanski V; Lambert M; Hatron PY; Humbert M; Launay D
    Arthritis Rheum; 2013 Sep; 65(9):2412-23. PubMed ID: 23740572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand.
    Foocharoen C; Nanagara R; Kiatchoosakun S; Suwannaroj S; Mahakkanukrauh A
    Int J Rheum Dis; 2011 Aug; 14(3):282-9. PubMed ID: 21816025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS).
    Kolstad KD; Li S; Steen V; Chung L;
    Chest; 2018 Oct; 154(4):862-871. PubMed ID: 29777655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
    Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
    Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population.
    Hachulla E; Clerson P; Airò P; Cuomo G; Allanore Y; Caramaschi P; Rosato E; Carreira PE; Riccieri V; Sarraco M; Denton CP; Riemekasten G; Pozzi MR; Zeni S; Mihai CM; Ullman S; Distler O; Rednic S; Smith V; Walker UA; Matucci-Cerinic M; Müller-Ladner U; Launay D;
    Rheumatology (Oxford); 2015 Jul; 54(7):1262-9. PubMed ID: 25596413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort.
    Noviani M; Saffari SE; Tan JL; Yip JWL; Teng GG; Law WG; Chan GYL; Santosa A; Lim AYN; Hong C; Ng SA; Tay ELW; Ruan W; Yap J; Low AHL
    Semin Arthritis Rheum; 2020 Jun; 50(3):473-479. PubMed ID: 31810742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study.
    Pasarikovski CR; Granton JT; Roos AM; Sadeghi S; Kron AT; Thenganatt J; Moric J; Chau C; Johnson SR
    Arthritis Res Ther; 2016 Jan; 18():30. PubMed ID: 26819137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA alleles in systemic sclerosis: association with pulmonary hypertension and outcome.
    Langevitz P; Buskila D; Gladman DD; Darlington GA; Farewell VT; Lee P
    Br J Rheumatol; 1992 Sep; 31(9):609-13. PubMed ID: 1525626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
    Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L;
    Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era.
    Launay D; Sitbon O; Hachulla E; Mouthon L; Gressin V; Rottat L; Clerson P; Cordier JF; Simonneau G; Humbert M
    Ann Rheum Dis; 2013 Dec; 72(12):1940-6. PubMed ID: 23178295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
    Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R
    Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after lung transplantation in systemic sclerosis. A systematic review.
    Khan IY; Singer LG; de Perrot M; Granton JT; Keshavjee S; Chau C; Kron A; Johnson SR
    Respir Med; 2013 Dec; 107(12):2081-7. PubMed ID: 24113572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
    Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
    Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
    Sobanski V; Giovannelli J; Lynch BM; Schreiber BE; Nihtyanova SI; Harvey J; Handler CE; Denton CP; Coghlan JG
    Arthritis Rheumatol; 2016 Feb; 68(2):484-93. PubMed ID: 26415038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
    Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
    Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of male sex on survival in systemic sclerosis.
    Hussein H; Lee P; Chau C; Johnson SR
    J Rheumatol; 2014 Nov; 41(11):2193-200. PubMed ID: 25274896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
    Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
    Mathai SC; Hummers LK; Champion HC; Wigley FM; Zaiman A; Hassoun PM; Girgis RE
    Arthritis Rheum; 2009 Feb; 60(2):569-77. PubMed ID: 19180517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is pulmonary arterial hypertension really a late complication of systemic sclerosis?
    Hachulla E; Launay D; Mouthon L; Sitbon O; Berezne A; Guillevin L; Hatron PY; Simonneau G; Clerson P; Humbert M;
    Chest; 2009 Nov; 136(5):1211-1219. PubMed ID: 19429720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.